Journal of Biomedical Nanotechnology

Our screening does not flag Journal of Biomedical Nanotechnology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, PubMed, which is a positive signal.

Per our venue index, Journal of Biomedical Nanotechnology appears in: Scopus, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

Papers in Journal of Biomedical Nanotechnology are cited about 0.7 times each within two years of publication, and Scimago places it in Q3, with an h-index of 91. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.

In the Scimago Journal Rank 2025 edition, Journal of Biomedical Nanotechnology is Q3 in 5 of its 6 subject categories and Q4 in the other 1. By category: Nanoscience and Nanotechnology: Q3, #54 of 73; Pharmaceutical Science: Q3, #99 of 195; Biomedical Engineering: Q3, #220 of 328; Materials Science (miscellaneous): Q3, #407 of 700; Medicine (miscellaneous): Q3, #1,589 of 2,517; Bioengineering: Q4, #126 of 165. Its best category quartile is Q3. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Journal of Biomedical Nanotechnology is cited about 0.7 times per paper over two years, with an h-index of 91.

The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Journal of Biomedical Nanotechnology. The open equivalent is its best Scimago quartile, Q3 in Nanoscience and Nanotechnology and 4 other categories, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.

Our index records its access status as "subscription". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.